Scientists from the University of Cambridge, Harvard Medical School and collaborators investigated the potential of ubiquitin carboxyl-terminal hydrolase 30 (USP30) inhibition as a therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback